Profiles

Keywords
Last Name
Institution

JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Agnihotri SP, Dang X, Carter JL, Fife TD, Bord E, Batson S, Koralnik IJ. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.

View in: PubMed

collapse authors with profiles